| Inventor | Institute |
|---|---|
| Lloyd J. Old, Germaine Trempe | Memorial Sloan-Kettering Cancer Center (MSK) |
| SKU: | 161923 |
|---|---|
| Product description: | This cell line has little or no phosphorylated retinoblastoma protein compared to the SK-UT-1B cells. SK-UT-1 cells are capable of forming tumours when inoculated in immunocompromised mice. |
| Gender: | Female |
| Additional notes: | The cells form spindle cell sarcomas. |
| Model description: | Tumourigenic in nude mice |
| Disease: | Ovarian cancer |
| Products or characteristics of interest: | Karyotype: (P8) hypodiploid to hyperdiploid. Isoenzymes: AK-1, 1; ES-D, 1; G6PD, B; Me-2, 1-2; PGM1, 1; PGM3, 1 |
| Cat. #: | 161923 |
|---|---|
| Cancer types: | Uterine cancer |
| Organism: | Human |
| Tissue: | Uterus |
| Gender: | Female |
| Model: | Tumourigenic |
| Morphology: | Epithelial |
| Growth properties: | Adherent |
| Cancer Types In Detail: | Ovarian |
| Primary citation: | Fogh et al. 1977. Journal of the National Cancer Institute. 59: 221-226. PMID: 327080. |
| Storage conditions: | Vapor phase of liquid nitrogen |
|---|---|
| Shipping conditions: | Dry Ice |
| Growth medium: | EMEM supplemented with FBS to a final concentration of 10%; formulated for use with a 5% CO2 in air atmosphere |
| Temperature: | 37° C |
| Atmosphere: | 5% CO2 in air |
| Storage medium: | Complete growth medium supplemented with 5% (v/v) DMSO |
| Biosafety level: | 1 |
| References: |
Ganiatsas et al. 2001. Oncogene. 20: 3641-50. PMID: 11439327. Li et al. 2013. International Journal of Gynecological Cancer. 23: 803-808. PMID: 23532091. |
|---|
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.